An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Childrens Hospital Colorado
University of Colorado Hospital
Study ID
Protocol Number: 20-2106
More information available at ClinicalTrials.gov: NCT04572854
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers